Towards a change of model in the management of benign prostatic hyperplasia: the importance of an individualized approach

array:21 ["pii" => "S2173578624001148" "issn" => "21735786" "doi" => "10.1016/j.acuroe.2024.10.001" "estado" => "S200" "fechaPublicacion" => "2024-11-04" "aid" => "1670" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:18 [ "pii" => "S0210480624001050" "issn" => "02104806" "doi" => "10.1016/j.acuro.2024.09.001" "estado" => "S200" "fechaPublicacion" => "2024-10-23" "aid" => "1670" "copyright" => "AEU" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "CARTA AL DIRECTOR" "titulo" => "Hacia un cambio de modelo en el manejo de la hiperplasia benigna de próstata: importancia de un enfoque individualizado" "tienePdf" => "es" "tieneTextoCompleto" => "es" "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Towards a change of model in the management of benign prostatic hyperplasia: the importance of an individualized approach" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 907 "Ancho" => 1450 "Tamanyo" => 103100 ] ] "descripcion" => array:1 [ "es" => "Conceptualización de los STUI/HBP HBP: hiperplasia benigna de próstata; STUI: síntomas del tracto urinario inferior." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Alcántara Montero" "autores" => array:1 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Alcántara Montero" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173578624001148" "doi" => "10.1016/j.acuroe.2024.10.001" "estado" => "S200" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173578624001148?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480624001050?idApp=UINPBA00004N" "url" => "/02104806/unassign/S0210480624001050/v1_202410230419/es/main.assets" ] ] "itemAnterior" => array:18 [ "pii" => "S2173578624000763" "issn" => "21735786" "doi" => "10.1016/j.acuroe.2024.05.016" "estado" => "S200" "fechaPublicacion" => "2024-05-30" "aid" => "1658" "copyright" => "AEU" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "The leaky pipeline and gender gaps in urology" "tienePdf" => "en" "tieneTextoCompleto" => "en" "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El leaking pipeline y las brechas de género en urología" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Medina Gamero" "autores" => array:1 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Medina Gamero" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S021048062400069X" "doi" => "10.1016/j.acuro.2024.05.001" "estado" => "S200" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021048062400069X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173578624000763?idApp=UINPBA00004N" "url" => "/21735786/unassign/S2173578624000763/v1_202405300422/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Towards a change of model in the management of benign prostatic hyperplasia: the importance of an individualized approach" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Alcántara Montero" "autores" => array:1 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "Alcántara Montero" "email" => array:1 [ 0 => "a.alcantara.montero@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Centro de Salud Trujillo, Consultorios de Herguijuela/Conquista de la Sierra Cáceres, Cáceres, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hacia un cambio de modelo en el manejo de la hiperplasia benigna de próstata: Importancia de un enfoque individualizado" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 907 "Ancho" => 1450 "Tamanyo" => 106426 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Conceptualization of LUTS/BPH. BPH: Benign prostatic hyperplasia; LUTS: Lower urinary tract symptoms." ] ] ] "textoCompleto" => "Following a detailed examination of the consensus on the clinical application of the UroLift® System in Spain for the treatment of lower urinary tract symptoms (LUTS) associated with urinary flow obstruction and secondary to benign prostatic hyperplasia (BPH),<a class="elsevierStyleCrossRef" href="#bib0005">1</a> I would like to present some reflections.As stated in the latest guidelines of the European Association of Urology, there is currently a large therapeutic armamentarium available for the management of BPH, including both pharmacological and surgical treatment options.<a class="elsevierStyleCrossRef" href="#bib0010">2</a> For this reason, patients must be informed of the different treatment options, including the associated risks and benefits, which will enable them to make an informed decision and increase their participation in choosing the most appropriate option.In most cases, the presence of filling symptoms is indicative of bladder dysfunction, such as detrusor overactivity, and has the greatest impact on quality of life.<a class="elsevierStyleCrossRef" href="#bib0015">3</a>It is important to note that the majority of studies on male LUTS secondary to prostatic obstruction classify severity using the International Prostate Symptom Score (IPSS), which is based on the assessment of symptoms. Information related to other aspects such as prostate size and flowmetry contributes to the diagnosis, but the classification of clinical severity is determined by the score of the IPSS. The prevailing initial assumption among clinicians is that benign prostatic hyperplasia (BPH) results in prostatic enlargement, which in turn causes bladder outlet obstruction and ultimately acute urinary retention. This is a well-established, valid hypothesis; however, it does not fully account for the natural history of male LUTS. This is a much more complex scenario; not all men with lower urinary tract symptoms (LUTS) follow this timeline. Hence, these concepts do not behave as concentric circles. It is known that not all men over the age of 40 with BPH will experience LUTS. Furthermore, the presence of BPH does not necessarily imply gland enlargement or obstruction, and the presence of LUTS may occur in the absence of these factors. (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). This paradigm shift has helped to establish symptomatic improvement and treatment satisfaction, both measured in a reliable way, as health goals to be achieved. Notwithstanding this, there is a need to enhance our comprehension of the underlying physiopathology of LUTS/BPH. As the field of male LUTS has evolved, clinicians have come to recognize the necessity for dependable and validated data, both for diagnostic purposes and for outcome assessment. To this end, patients represent the primary source of information. Consequently, the introduction of more reliable assessment tools, and greater patient awareness of their condition, will result in improved overall health outcomes.<elsevierMultimedia ident="fig0005"></elsevierMultimedia>FundingThe author declares that no funding has been received." "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2024-09-23" "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 907 "Ancho" => 1450 "Tamanyo" => 106426 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Conceptualization of LUTS/BPH. BPH: Benign prostatic hyperplasia; LUTS: Lower urinary tract symptoms." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aplicación clínica del sistema de liberación uretral UroLift® en España: consenso sobre el tratamiento de los síntomas del tracto urinario inferior asociados a la obstrucción del flujo urinario por hiperplasia benigna de próstata" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Fernández Arjona" 1 => "L. López Martín" 2 => "L.M. Herranz Fernández" 3 => "B. Sinues Ojas" 4 => "J.M. Campá Bortoló" 5 => "J. Extramiana Cameno" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.acuro.2024.06.003" "Revista" => array:2 [ "tituloSerie" => "Actas Urol Esp." "fecha" => "2024" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "EAU Guidelines on Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.N. Cornu" 1 => "M. Gacci" 2 => "H. Hashim" 3 => "T.R.W. Herrmann" 4 => "S. Malde" 5 => "C. Netsch" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2024" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2024.pdf" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Perfil de síntomas del tracto urinario inferior en el varón y su impacto en la calidad de vida" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Cambronero" 1 => "S. Arlandis" 2 => "C. Errando" 3 => "A.M. Mora" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.acuro.2012.11.011" "Revista" => array:6 [ "tituloSerie" => "Actas Urol Esp." "fecha" => "2013" "volumen" => "37" "paginaInicial" => "401" "paginaFinal" => "407" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23411069" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735786/unassign/S2173578624001148/v1_202411040359/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/21735786/unassign/S2173578624001148/v1_202411040359/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173578624001148?idApp=UINPBA00004N"]

ISSN: 2173-5786

Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology. Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided. It has high visibility and accessibility and is found in the most important data bases, Medline/Pubmed, Emabase, JCR, Ïndice Médico Español, Índice bibliográfico Español en Ciencias de la Salud (IBECS), Cuiden, Dialnet, Hinari, Scopus, Google Scholar.

See more Open Access Option

Indexed in:

Science Citation Index Expanded, Journal of Citation Reports, Index Medicus/MEDLINE, Scopus, EMBASE/Excerpta Medica, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.332

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.557

View more metrics

Journal Information

Lee este artículo en Español

Export reference

Download PDF

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)

Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”

Subscribe to

Actas Urológicas Españolas (English Edition)

More information

Purchase

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now

Contact

Phone for subscriptions and reporting of errors

From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.

Calls from Spain

932 415 960

Calls from outside Spain

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Publish in

Actas Urológicas Españolas

Actas Urológicas Españolas (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Free access articles

Recommendations on the treatment of metastatic...

Actas Urol Esp. 2024;48:623-31

Changes in benign prostatic hyperplasia management in...

Actas Urol Esp. 2024;48:461-9

Long-term functional success and patient-reported outcomes...

10.1016/j.acuroe.2024.05.014

Indexed in:

Follow us:

Subscribe:

Article

Subscribe to our newsletter